<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0140">
 <label>28</label>
 <element-citation publication-type="journal" id="rf0135">
  <person-group person-group-type="author">
   <name>
    <surname>Galloway</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Hyrich</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Mercer</surname>
    <given-names>L.K.</given-names>
   </name>
   <name>
    <surname>Dixon</surname>
    <given-names>W.G.</given-names>
   </name>
   <name>
    <surname>Fu</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ustianowski</surname>
    <given-names>A.P.</given-names>
   </name>
  </person-group>
  <article-title>Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology biologics register with special emphasis on risks in the elderly</article-title>
  <source>Rheumatology (Oxford)</source>
  <volume>50</volume>
  <year>2010</year>
  <fpage>124</fpage>
  <lpage>131</lpage>
  <pub-id pub-id-type="doi">10.1093/rheumatology/keq242</pub-id>
  <pub-id pub-id-type="pmid">20675706</pub-id>
 </element-citation>
</ref>
